In English | En español
Questions About Cancer? 1-800-4-CANCER

Malignant Mesothelioma Treatment (PDQ®)

  • Last Modified: 10/27/2011

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document

Changes to This Summary (10/27/2011)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Malignant Mesothelioma Treatment

Added de Perrot et al. as reference 4.

Stage Information for Malignant Mesothelioma

Updated staging information for 2010 (cited Edge et al. as reference 2).

Advanced Malignant Mesothelioma (Stages II, III, and IV)

Added de Perrot et al. as reference 12.

Added text about a large randomized study from the United Kingdom (BTS-MRC-MS01) that compared active symptom control (ASC) with the chemotherapy regimens of mitomycin C, vinblastine, and cisplatin (MVP) or single-agent vinorelbine and showed that despite some changes to the original trial design, no significant difference in survival was detected between ASC and chemotherapy (cited Muers et al. as reference 17 and level of evidence 1iiA).